Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer

Pienta, Kenneth J. ; Machiels, Jean-Pascal ; Schrijvers, Dirk ; Alekseev, Boris ; Shkolnik, Mikhail ; Crabb, Simon J. ; Li, Susan ; Seetharam, Shobha ; Puchalski, Thomas A. ; Takimoto, Chris ; Elsayed, Yusri ; Dawkins, Fitzroy ; de Bono, Johann S.

Investigational new drugs, 2013-06, Vol.31 (3), p.760-768 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível